Skip to content
Search

Latest Stories

DHSC updates June 2023 price concessions after CPE members report medicine pricing issues

Department of Health and Social Care (DHSC) has updated the final price concessions for June 2023, following a discussion by Community Pharmacy England regarding medicine pricing issues reported by pharmacy owners (its members).

A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.


Community Pharmacy England encouraged pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website along with full details of the supplier and price paid for any products sourced above the Drug Tariff price.

The association will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.

“Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system,” said CPE.

One of the solutions agreed between CPE and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.

Furthermore, from May 2023, DHSC has implemented a process to roll over prices to the following month for any concessions requested after the 23rd of the month provided these prices were agreed with us.

CPE is also continuing to work with DHSC on how a ‘retrospective increased payment’ my apply, when appropriate.

Full list below:

DrugPack sizePrice concession
* Alginate raft-forming oral suspension sugar free500£3.80
Amiloride 5mg tablets28£13.46
Amoxicillin 125mg/5ml oral suspension sugar free100£2.68
Benzoyl peroxide 5% / Clindamycin 1% gel60£22.22
Buprenorphine 8mg sublingual tablets sugar free7£11.36
Calamine lotion200£1.86
Chloramphenicol 0.5% eye drops10£12.51
Chlorphenamine 2mg/5ml oral solution sugar free150£4.01
Clotrimazole 500mg pessary and Clotrimazole 2% cream1£10.79
Co-careldopa 12.5mg/50mg tablets90£4.93
Co-trimoxazole 80mg/400mg tablets28£2.34
Docusate 50mg/5ml oral solution sugar free300£18.81
Flucloxacillin 250mg capsules28£2.45
Isoniazid 100mg tablets28£60.00
Ivabradine 5mg tablets56£28.33
Letrozole 2.5mg tablets14£6.66
Methylphenidate 5mg tablets30£3.45
Mometasone 0.1% cream30£3.60
Mycophenolate mofetil 500mg tablets50£7.69
Pantoprazole 20mg gastro-resistant tablets28£6.62
Pantoprazole 40mg gastro-resistant tablets28£9.23
Paracetamol 500mg effervescent tablets100£10.34
Pregabalin 300mg capsules56£4.02
Promethazine hydrochloride 25mg tablets56£29.32
Quinine sulfate 200mg tablets28£7.97
Risperidone 500microgram tablets20£2.98
Rosuvastatin 20mg tablets28£4.98
Sodium chloride 0.9% nebuliser liquid 2.5ml unit dose ampoules20£11.04
Tacrolimus 0.1% ointment60£41.69
Tacrolimus 0.1% ointment30£22.36
Tamsulosin 400microgram / Dutasteride 500microgram capsules30£14.53
Tolterodine 2mg tablets56£3.55
Topiramate 100mg tablets60£16.53
Tramadol 37.5mg / Paracetamol 325mg tablets60£7.38
Trazodone 50mg capsules84£3.45
Venlafaxine 75mg tablets56£11.51
Zolmitriptan 2.5mg tablets6£18.85
Zolmitriptan 2.5mg tablets12£37.70

More For You

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less